Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1997-3-21
pubmed:abstractText
Midazolam is the sedating agent of choice in many paediatric intensive care units, and is usually administered as a continuous intravenous infusion with or without a preceding bolus dose. Ten haemodynamically stable children, ventilated in the early postoperative period after cardiac surgery and receiving intravenous morphine infusions, were given an intravenous bolus followed by a continuous infusion of midazolam. Haemodynamic data were recorded before the bolus, and 15 minutes and one hour later. A bolus of midazolam lowered the cardiac output by 24.1%. Arterial blood pressure, oxygen consumption, and mixed venous oxygen content fell significantly. There was a tendency for all variables subsequently to recover towards baseline values, within one hour, during a continuous infusion. An intravenous bolus of midazolam causes a transient but unwanted fall in cardiac output. It is suggested that in children who are receiving intravenous opiates, its use in the early postoperative period be limited to a continuous infusion.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-1774406, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-1774407, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-2869711, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-2919767, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-2936281, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-3006554, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-3156545, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-3344980, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-3768222, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-441578, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-6108124, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-6980657, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-7201758, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-8020271, http://linkedlifedata.com/resource/pubmed/commentcorrection/9059164-876354
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1468-2044
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
76
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
57-61
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1997
pubmed:articleTitle
Cardiovascular effects of intravenous midazolam after open heart surgery.
pubmed:affiliation
Department of Paediatric Cardiology, Royal Brompton Hospital/National Heart and Lung Institute (Imperial College of Science, Technology and Medicine), London.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't